Inflammation-Related Factors S100A9 and TLR2 in Cardiomyocyte Hypertrophy

Ke-Jia Jin1, Le Pan1, Chen-Xing Huang1

  • 1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.

PubMed

Insights

Inflammatory mediators S100A9 and Toll-like receptor 2 (TLR2) amplify heart failure progression through reciprocal activation, worsening cardiac remodeling and hypertrophy.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Heart failure (HF) pathogenesis involves complex pathways, including immune dysregulation and cardiac remodeling.
  • Specific inflammatory mediators contribute to cardiac remodeling, but mechanisms are unclear.

Purpose of the Study:

  • To investigate the role of immune-related genes in heart failure and hypertrophic cardiomyopathy.
  • To elucidate the molecular mechanisms linking inflammation and cardiac hypertrophy.

Main Methods:

  • Integrated bioinformatics analysis of HF and hypertrophic cardiomyopathy transcriptomic data.
  • Construction of protein-protein interaction networks and module analysis.
  • Validation using in vitro (mechanical stretch) and in vivo (transverse aortic constriction) models.

Main Results:

  • Significant association found between immune function and cardiac remodeling.
  • S100 calcium-binding protein A9 (S100A9) and Toll-like receptor 2 (TLR2) identified as key inflammatory factors.
  • Elevated S100A9 in HF patients and cardiomyocytes correlated with hypertrophy markers; S100A9 upregulated TLR2, which was attenuated by inhibition.

Conclusions:

  • S100A9 and TLR2 exhibit reciprocal activation, amplifying cardiomyocyte hypertrophy.
  • This inflammatory cross-talk exacerbates maladaptive cardiac remodeling and HF progression.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
33
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
45
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
46
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K